Exchange Traded Concepts’s Amedisys AMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-8,758
Closed -$862K 1450
2025
Q2
$862K Buy
8,758
+168
+2% +$15.9K 0.01% 733
2025
Q1
$796K Buy
8,590
+887
+12% +$81.8K 0.01% 669
2024
Q4
$699K Buy
7,703
+195
+3% +$17.9K 0.01% 724
2024
Q3
$725K Buy
7,508
+450
+6% +$43.9K 0.02% 684
2024
Q2
$648K Buy
7,058
+333
+5% +$30.9K 0.02% 607
2024
Q1
$620K Buy
6,725
+203
+3% +$19K 0.02% 622
2023
Q4
$620K Hold
6,522
0.02% 536
2023
Q3
$609K Buy
+6,522
New +$603K 0.02% 501
2022
Q1
Sell
-2,808
Closed -$455K 1200
2021
Q4
$455K Buy
2,808
+219
+8% +$35.2K 0.01% 699
2021
Q3
$386K Buy
2,589
+696
+37% +$145K 0.01% 691
2021
Q2
$464K Sell
1,893
-33
-2% -$8.66K 0.01% 653
2021
Q1
$510K Buy
1,926
+64
+3% +$18K 0.02% 466
2020
Q4
$546K Buy
1,862
+171
+10% +$43.8K 0.03% 336
2020
Q3
$400K Buy
+1,691
New +$384K 0.02% 349

Other funds holding AMED

Exchange Traded Concepts's AMED Position: Q3 2025 in Review

Exchange Traded Concepts sold out of Amedisys (AMED) in Q3 2025, closing a stake of 8,758 shares — an estimated $862K sold.

Exchange Traded Concepts first reported a position in AMED in Q3 2020 and held it in 14 quarters. The position peaked at $862K in Q2 2025. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.

  • Exchange Traded Concepts reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
  • Exchange Traded Concepts sold 8,758 Amedisys shares in Q3 2025, an estimated $862K.
  • Exchange Traded Concepts first reported a position in Amedisys in Q3 2020 and held it in 14 quarters.
  • Exchange Traded Concepts's Amedisys position peaked at $862K in Q2 2025.
  • 4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.

Based on Exchange Traded Concepts's 13F filing for Q3 2025, filed 14 Oct 2025.